Deimination and expression of peptidylarginine deiminases during cutaneous wound healing in mice
Authors:
- Marie-Claire MechinMMMarie-Claire Mechin
- Anne HuchenqAHAnne Huchenq
- Julie HenryJHJulie Henry
- Rachida NachatRNRachida Nachat
- Akihito IshigamiAIAkihito Ishigami
- Véronique AdoueVéronique Adoue
- Mireille SebbagMSMireille Sebbag
- Guy SerreGSGuy Serre
- Michel SimonMichel Simon
- 1 May 2011
- journal article
- research article
- Published by JLE in European Journal Of Dermatology
- Vol. 21 (3) , 376-384
Abstract
Deimination, the conversion of protein-bound arginines into citrullines, is a post-translational modification catalyzed by a peptidylarginine deiminase (Pad). In the epidermis, three Pads are expressed, namely Pad1, 2 and 3, and the major deiminated protein is filaggrin. Deimination of fibrin has been observed in various pathological inflammatory conditions. Here, we analyzed the expression of Pads and citrullination of proteins during cutaneous wound healing, i.e. in a physiological inflammatory condition. Full-thickness punches were performed on adult mouse back skin, and wound recovery was analyzed over 10 days by immunohistology and western blotting. Pad1 was immunodetected in all the neo-epidermis. Pad3, normally expressed in the stratum granulosum, was not detected in the hyperproliferative tongue of the neo-epidermis, but was shown to be co-localized with (pro)filaggrin in a large number of keratinocyte layers in its differentiating part. Deiminated proteins were detected in the stratum corneum of the neo-epidermis in the late phase of re-epithelialization, and in the clot and the clot-derived scab. In the clot where we only detected Pad4, one of the deiminated proteins was shown to be fibrin. Deimination of the clot proteins, and more generally wound healing and keratinocyte differentiation, seemed to be Pad2-independent, as shown using Padi2(-/-) mice.Keywords
This publication has 28 references indexed in Scilit:
- Developmental and age‐related changes of peptidylarginine deiminase 2 in the mouse brainJournal of Neuroscience Research, 2009
- Long-Range Enhancer Differentially Regulated by c-Jun and JunD Controls Peptidylarginine Deiminase-3 Gene in KeratinocytesJournal of Molecular Biology, 2008
- Peptidyl arginine deiminase type 2 (PAD‐2) and PAD‐4 but not PAD‐1, PAD‐3, and PAD‐6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammationArthritis & Rheumatism, 2007
- Biphasic Regulation of AP-1 Subunits during Human Epidermal Wound HealingJournal of Investigative Dermatology, 2007
- Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertilityMolecular and Cellular Endocrinology, 2007
- Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout miceJournal of Comparative Neurology, 2006
- Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumorsThe International Journal of Biochemistry & Cell Biology, 2006
- The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locationsCellular and Molecular Life Sciences, 2005
- Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's diseaseJournal of Neuroscience Research, 2005
- Citrullination of synovial proteins in murine models of rheumatoid arthritisArthritis & Rheumatism, 2003